Targeting polo-like kinase 1: advancements and future directions in anti-cancer drug discovery.

Raab, Monika; Becker, Sven; Sanhaji, Mourad

Raab, Monika; Becker, Sven; Sanhaji, Mourad.

Affiliation

Raab M; School of Medicine, Department of Obstetrics and Gynecology, J.W. Goethe University, Frankfurt, Germany.
Becker S; School of Medicine, Department of Obstetrics and Gynecology, J.W. Goethe University, Frankfurt, Germany.
Sanhaji M; School of Medicine, Department of Obstetrics and Gynecology, J.W. Goethe University, Frankfurt, Germany.

Expert Opin Drug Discov ; : 1-5, 2024 Jul 29.

Article de En | MEDLINE | ID: mdl-39075888

Mots clés

ATP-competitive inhibitors; Polo-like kinase (PLK1) inhibitors; cancer therapy; polo-box domain (PBD) inhibitors

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Expert Opin Drug Discov Année: 2024 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google